Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary

3 years ago

PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--#FibroScan--Echosens, a high-technology company offering the FibroScan® portfolio of solutions, is pleased to celebrate its 20th…

Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence

3 years ago

Major milestone achieved in Company's advance toward a new U.S. SUI indicationENGLEWOOD, CO / ACCESSWIRE / December 14, 2021 /…

Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma

3 years ago

GIANT-1 study to evaluate once-daily oral inhalation of novel catalytic antisense oligonucleotide formulation SB010 in patients with moderate to severe…

Going Up: CLS Holdings USA, Inc. Announces November Results With Record Breaking Gross Profit Margin

3 years ago

LAS VEGAS, NV / ACCESSWIRE / December 14, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a…

StageZero Life Sciences Announces Formation of Scientific Advisory Board

3 years ago

Noted industry experts Dr. Barry Boyd, Dr. Jason Fung, and Benjamin Bikman, Ph.D. join StageZero Life Sciences' Scientific Advisory Board…

Roche’s Polivy combination reduced the risk of disease worsening or death by 27% in people with previously untreated aggressive form of lymphoma

3 years ago

Polivy plus R-CHP is the first treatment regimen to significantly improve outcomes in previously untreated diffuse large B-cell lymphoma in…

Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH’s plenary and late-breaking sessions

3 years ago

Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or…

Rockwell Medical Receives Important Feedback from FDA on its IND Application for Phase 2 Trial of Ferric Pyrophosphate Citrate in Home Infusion

3 years ago

WIXOM, Mich., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment…

Ozop Energy Solutions to Introduce EV Protection Products

3 years ago

Florida, NY, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. (OZSC), (“Ozop” or the “Company”), today announced its plans…